Our Expertise
Public-Private Partnerships Drive Healthcare Progress in SEA
Public-private partnerships (PPPs) are playing a pivotal role in strengthening Southeast Asia’s healthcare systems by expanding access, enhancing infrastructure, and fostering innovation amid growing demand and resource constraints.

Southeast Asia’s healthcare landscape is undergoing a significant transformation, driven by demographic shifts, economic growth, and evolving health challenges. A recent whitepaper by DKSH Business Unit Healthcare and FrontierView, a market intelligence and advisory firm, shows that healthcare financing in Southeast Asia is projected to expand by 68% over the next five years – a growth rate that significantly surpasses that of most developed and developing markets.
The potential in healthcare services is immense and continues to grow as the region’s population expands and matures. At the same time, Southeast Asia’s rapidly developing economies such as Malaysia and Thailand are driving increased purchasing power for both governments and individuals, further fueling demand for healthcare solutions.
Public Healthcare Turns to Private Support
Although healthcare financing has improved, gaps are beginning to show with many social security payers falling into deficit in 2023 and out-of-pocket costs increasing. Even Singapore, the wealthiest market in the region, has seen a decline in fully covered hospital stays, prompting discussions on premium hikes and co-payment models. By the end of 2023, inpatient visits in public hospitals, except in Vietnam, had rebounded to or exceeded pre-pandemic levels. A combination of higher patient volumes, increased care costs, worsening patient conditions, and expanded reimbursement lists has pushed many public healthcare payers into deficit.
With rising demand, financial pressures, and workforce shortages, governments are struggling to expand public hospital capacity in line with population growth. As a result, the past two years have seen an increasing effort to collaborate with private providers through PPPs to ensure public patient access to healthcare. PPPs in Southeast Asia have been instrumental in bridging gaps in healthcare access, infrastructure, and innovation. Governments collaborate with private entities to leverage resources, expertise, and efficiencies that neither sector could achieve alone.
In the Philippines, the government has actively pursued PPPs to sustain and enhance state healthcare provision. Recognizing the need for private sector investment, the market has implemented projects where private entities contribute to the development and management of healthcare facilities and services.
Similarly, Indonesia has encouraged private sector involvement in healthcare by revising regulations to attract foreign investment. Malaysia’s PPP model has also enhanced access to comprehensive care, improved quality management, and strengthened service delivery through various funding and sponsorship initiatives. These partnerships have led to significant investments in healthcare infrastructure, including the development of hospitals, clinics, and diagnostic centers.
Healthcare Insurance: The Intersection of PPPs
PPPs have played a crucial role in expanding access to insurance products for underserved populations in Southeast Asia. Government collaboration has also been pivotal in supporting these PPPs in the insurance sector. By creating conducive regulatory frameworks and policies, governments enable private companies to offer innovative insurance products.
Many innovative insurance models have emerged from these combined efforts. For example, microinsurance schemes have been developed to provide affordable health coverage to lower-income individuals. These schemes often involve partnerships between governments, private insurers, and non-governmental organizations to pool resources and share risks.
Numerous insurers and banks in Singapore also now offer microinsurance, which has brought accessibility and flexibility in insurance to those who are typically limited in their insurance options. The region is reflective of this progress with research indicating that Asia will be leading the microinsurance market. This collaboration benefits the underserved populations and allows private insurers to tap into new markets, creating a holistically positive outcome for all parties involved.
Successes like this aside, many potential challenges still exist in this sphere. Regulatory hurdles can impede the swift implementation of such projects, while cultural differences may affect the acceptance of private sector involvement. Additionally, misalignment between public and private sector goals can lead to discussions, especially when business performance motives clash with public health objectives.
The Potential of PPPs
Looking ahead, PPPs have the potential to evolve and scale insurance accessibility and healthcare service delivery across the region’s diverse populations. Continued innovation in insurance models, supported by robust policy frameworks, can further reduce barriers to healthcare access.
Moreover, as digital health ecosystems develop, PPPs can leverage technology to enhance service delivery and expand reach. This way, the future of healthcare and its related insurance in Southeast Asia will be defined by greater inclusivity, sustainability, and resilience, ensuring quality care for all.
This article was published in Asian Insurance Review.
About the Author
Bijay Singh
Bijay Singh joined DKSH as Vice President, Global Business Development for Business Unit Healthcare in July 2015. He was designated Head Business Unit Healthcare and a member of the Executive Committee in July 2017.He has over 30 years of experience in the healthcare industry and amassed over 20 years of work experience in the healthcare field across Asia. He holds a Bachelor of Business Administration (Hons) from Simon Fraser University, Canada, and a Master’s degree in Business Administration from Stanford University, USA.

Related Insights

Future-Ready Electronics Start With Precision Testing

Transforming Healthcare in Asia Pacific: The Impact of Medical Devices

The Critical Role of Active Pharmaceutical Ingredient Distributors in the Pharmaceutical Industry

Healthtech Revolution Is Transforming Healthcare in Thailand
Contact Us